| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
5-hydroxytryptamine receptor 6 | 0.626 | 0.500 | 1.9E-04 |
|
group | 0.320 | None | 1.000 | 3 | 0 | 1999 | 2010 | ||||||||
|
interleukin 9 receptor | 0.659 | 0.654 | 2.7E-22 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
tachykinin receptor 1 | 0.502 | 0.885 | 3.8E-04 |
|
group | 0.320 | None | 1.000 | 5 | 0 | 2000 | 2014 | ||||||||
|
prodynorphin | 0.535 | 0.577 | 1.7E-04 |
|
group | 0.330 | None | 1.000 | 5 | 0 | 2000 | 2012 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.370 | None | 0.750 | 4 | 0 | 2000 | 2020 | ||||||||
|
5-hydroxytryptamine receptor 5A | 0.716 | 0.231 | 6.3E-03 |
|
group | 0.330 | None | 0.333 | 3 | 0 | 2000 | 2010 | ||||||||
|
dual specificity phosphatase 6 | 0.511 | 0.846 | 0.98 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
corticotropin releasing hormone | 0.439 | 0.808 | 0.72 |
|
group | 0.400 | None | 1.000 | 5 | 0 | 2001 | 2019 | ||||||||
|
DISC1 scaffold protein | 0.548 | 0.769 | 1.7E-06 |
|
group | 0.400 | None | 1.000 | 5 | 0 | 2001 | 2018 | ||||||||
|
5-hydroxytryptamine receptor 2C | 0.555 | 0.692 | 3.7E-02 |
|
group | 0.350 | None | 0.800 | 5 | 0 | 2001 | 2015 | ||||||||
|
opioid receptor kappa 1 | 0.555 | 0.615 | 4.1E-05 |
|
group | 0.340 | None | 1.000 | 4 | 0 | 2001 | 2019 | ||||||||
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 | 0.529 | 0.808 | 1.00 |
|
group | 0.320 | None | 1.000 | 2 | 0 | 2001 | 2002 | ||||||||
|
neuropeptide Y receptor Y2 | 0.612 | 0.577 | 3.6E-02 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 2001 | 2006 | ||||||||
|
disrupted in schizophrenia 2 | 0.716 | 0.192 |
|
group | 0.320 | None | 1.000 | 2 | 0 | 2001 | 2004 | |||||||||
|
G protein subunit beta 3 | 0.518 | 0.808 | 3.3E-11 |
|
group | 0.330 | None | 1.000 | 2 | 0 | 2001 | 2003 | ||||||||
|
inositol monophosphatase 2 | 0.695 | 0.385 | 1.1E-03 |
|
group | 0.320 | None | 0.500 | 2 | 0 | 2001 | 2007 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
group | 0.400 | None | 1.000 | 5 | 0 | 2002 | 2020 | ||||||||
|
cAMP responsive element binding protein 1 | 0.463 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.800 | 5 | 0 | 2002 | 2014 | ||||||||
|
nuclear receptor subfamily 3 group C member 1 | 0.393 | 0.885 | 0.97 |
|
group | 0.600 | None | 0.800 | 5 | 0 | 2002 | 2018 | ||||||||
|
corticotropin releasing hormone receptor 2 | 0.584 | 0.731 | 8.5E-17 |
|
group | 0.320 | None | 1.000 | 3 | 0 | 2002 | 2006 | ||||||||
|
solute carrier family 6 member 2 | 0.490 | 0.846 | 8.2E-02 |
|
group | 0.320 | None | 1.000 | 3 | 0 | 2002 | 2011 | ||||||||
|
5-hydroxytryptamine receptor 4 | 0.610 | 0.615 | 2.5E-02 |
|
group | 0.310 | None | 1.000 | 2 | 0 | 2002 | 2010 | ||||||||
|
clock circadian regulator | 0.463 | 0.885 | 1.00 |
|
group | 0.400 | None | 1.000 | 5 | 0 | 2003 | 2019 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 2A | 0.522 | 0.808 | 1.00 |
|
group | 0.330 | None | 1.000 | 3 | 0 | 2003 | 2017 |